132 Results for "

sGC

" in MedChemExpress (MCE) Product Catalog:
Products (132)

132 Results for "sGC" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-145446
CAS No.: 1997319-84-2
Purity:  99.84%
Target:  

SWI/SNF Complex

Research Areas:  

Metabolic Disease

SGC-SMARCA-BRDVIII, a chemical probe, is a potent and selective inhibitor of SMARCA2/4 and PB1(5), with Kds of 35 nM, 36 nM, and 13 nM, respectively. SGC-SMARCA-BRDVIII also inhibits PB1(2) and PB1(3), with Kds of 3.7 and 2.0 μM, respectively. SGC-SMARCA-BRDVIII can block adipogenesis of 3T3-L1 murine fibroblasts .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100565
CAS No.: 1821908-48-8
Purity:  99.46%
Research Areas:  

Cancer

SGC2085 is a potent and selective inhibitor of coactivator associated arginine methyltransferase 1 (CARM1) with an IC50 of 50 nM. SGC2085 also selectively inhibits PRMT6 with an IC50 value of 5.2 μM, but not other PRMT proteins .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-123940
CAS No.: 2247894-32-0
Purity:  98.93%
Target:  

Wnt AAK1

Research Areas:  

Cancer

SGC-AAK1-1, a chemical probe, is a potent and selective AAK1 (AP2 associated kinase 1) inhibitor with an IC50 of 270 nM and a Ki of 9 nM. SGC-AAK1-1 also potently inhibits BMP2K. SGC-AAK1-1 is used to study Wnt pathway related to AAK1 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W015084
CAS No.: 14901-07-6
β-Ionone is effective in the induction of apoptosis in gastric adenocarcinoma SGC7901 cells. Anti-cancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109136
CAS No.: 1402936-61-1
Purity:  99.31%
Synonyms: BAY 1101042
Runcaciguat (BAY 1101042) is a selective, orally active, allosteric activator of soluble guanylate cyclase (sGC) that specifically targets its oxidized and heme-free form. Runcaciguat binds to sGC in a histidine-dependent manner and restores cyclic guanosine monophosphate (cGMP) production under oxidative stress, independent of nitric oxide (NO) or heme. Runcaciguat exhibits renoprotective and cardioprotective activities, such as reduced proteinuria and improved renal function. Runcaciguat is primarily being studied in chronic kidney disease (CKD) associated with hypertension, diabetes, and metabolic disorders, as well as potential cardiovascular indications such as heart failure with preserved ejection fraction (HFpEF) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111457A
CAS No.: 675103-36-3
Purity:  99.59%
Target:  

Elastase

Research Areas:  

Inflammation/Immunology

BAY-678 is an orally bioavailable, highly potent, selective and cell-permeable inhibitor of human neutrophil elastase (HNE), with an IC50 of 20 nM. BAY-678 is also nominated as a chemical probe to the public via the Structural Genomics Consortium (SGC).
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109066
CAS No.: 1628732-62-6
Purity:  98.44%
Synonyms: IW-1701
Target:  

Guanylate Cyclase

Research Areas:  

Cardiovascular Disease

Olinciguat (IW-1701) is an oral guanylate cyclase (sGC) stimulator with concentration-dependent stimulation of sGC in purified rat and human enzyme assays and a whole cell assay .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19714
CAS No.: 1624117-53-8
Target:  

Drug Derivative

Research Areas:  

Cancer

XY1 is an analog of SGC707 (HY-19715), a potent and selective PRMT3 inhibitor with an IC50 of 31 nM. XY1 is completely inactive against PRMT3. XY1 and SGC707 represent an excellent pair of tools for further elucidating the biological functions and disease relevance of PRMT3 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-155360
CAS No.: 3008262-76-5
Purity:  99.05%
Target:  

YAP Apoptosis

Research Areas:  

Cancer

MY-1076 is an inhibitor of YAP. MY-1076 induces YAP degradation and cell apoptosis. MY-1076 inhibits MGC-803, SGC-7901, HCT-116 and KYSE450 cells proliferation with IC50 s of 0.019, 0.017, 0.020 and 0.044 μM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117604
CAS No.: 1257051-63-0
Purity:  98.75%
Research Areas:  

Neurological Disease

THPP-1, a SGC chemical probe, is a potent and orally bioavailable phosphodiesterase 10A (PDE10A) inhibitor, with Ki values of 1 nM and 1.3 nM for human and rat PDE10A, respectively. THPP-1 has excellent pharmacokinetic properties in preclinical species .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111457
CAS No.: 2117404-84-7
Purity:  98.02%
Target:  

Elastase

Research Areas:  

Inflammation/Immunology

BAY-677 is an inactive control for BAY-678. BAY-678 is an orally bioavailable, highly potent, selective and cell-permeable inhibitor of human neutrophil elastase (HNE), with an IC50 of 20 nM . BAY-678 is also nominated as a chemical probe to the public via the Structural Genomics Consortium (SGC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12379
CAS No.: 204326-43-2
Purity:  99.58%
Target:  

Guanylate Cyclase

Research Areas:  

Inflammation/Immunology

NS-2028 is a highly selective soluble Guanylyl Cyclase (sGC) inhibitor with IC50 values of 30 nM and 200 nM for basal and NO-stimulated enzyme activity . NS-2028 inhibits soluble Guanylyl Cyclase activity in homogenates of mouse cerebellum and neuronal NO synthase with IC50 values of 17 nM and 20 nM . NS-2028 inhibits 3-morpholino-sydnonimine (SIN-1)-elicited formation of cyclic GMP in human cultured umbilical vein endothelial cells with an IC50 of 30 nM . NS-2028 is commonly used in the research of nitric oxide signaling pathways, it inhibits NO-dependent relaxant responses in non-vascular smooth muscle completely (1 μM) . NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability .
loading...
    loading...
Cat. No.: HY-113926
CAS No.: 1027642-43-8
Purity:  98.15%
Target:  

Guanylate Cyclase

Research Areas:  

Cardiovascular Disease

BAY 60-2770 is a potent, selective, and orally active soluble guanylyl cyclase (sGC) activator. BAY 60-2770 increases the activity of sGC in a nitric oxide-independent manner. BAY 60-2770 shows antifibrotic effect .
loading...
    loading...
Cat. No.: HY-114211
CAS No.: 3062376-84-2
Purity:  97.6%
Research Areas:  

Cancer

SGC8158 is an inhibitor of PRMT7 and can be used to study the cellular function of PRMT7. SGC8158 decreases monomethylarginine levels of Hsp70 (the best characterized PRMT7 substrate). SGC8158 induces growth inhibition in various cancer cells (IC50: 2-9 μM), as well as multidrug-resistant (MDR) cancer cells. SGC8158 also enhances Doxorubicin (HY-15142A) induced DNA damage and Its cytotoxicity .
loading...
    loading...
Cat. No.: HY-155805
Purity:  99.85%
Target:  

CDK

Research Areas:  

Cancer

CAF-382 (compound B1) is an analog of SNS-032 and a CDKL5 and pan-CDK inhibitor with a weak GSK3α/β affinity (>1.8 μM) and inhibitory activity. CAF-382 inhibits CDKL5 and blocks the phosphorylation of the CDKL5 E2 domain .
loading...
    loading...
Cat. No.: HY-153708
CAS No.: 748142-15-6
Purity:  99.12%
Synonyms: CAF-170
Target:  

CDK

Research Areas:  

Cancer

SGC-CLK-1, a chemical probe, is a potent and selective inhibitor of Cdc2-like kinases CLK1, CLK2, and CLK4. SGC-CLK-1 can inhibit the growth of melanoma and glioblastoma cells .
loading...
    loading...
Cat. No.: HY-168905
CAS No.: 2561494-76-4
Target:  

Calmodulin

Research Areas:  

Cancer

SGC-CAMKK2-1, a chemical probe, is the selective, inhibitor for calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) with an IC50 of 30 nM. SGC-CAMKK2-1 inhibits AMPK phosphorylation in cell C4-2 with an IC50 of 1.6 μM .
loading...
    loading...
Cat. No.: HY-147083
CAS No.: 2242913-80-8
Target:  

AAK1

Research Areas:  

Cancer

SGC-AAK1-1N is a potent and selective AAK1 (AP2 associated kinase 1) inhibitor, with an IC50 of 1.8 μM .
loading...
    loading...
Cat. No.: HY-156350
CAS No.: 2650530-00-8
Purity:  98.5%
Target:  

DAPK

Research Areas:  

Cancer

SGC-STK17B-1, a chemical probe, is an ATP-competitive and selective STK17B (a member of DAPK family) inhibitor (IC50: 34 nM, KD: 5.6 nM) .
loading...
    loading...
Cat. No.: HY-172118
CAS No.: 844442-32-6
Target:  

GSK-3

Research Areas:  

Neurological Disease

CDKL5/GSK3-IN-1 (Compound 2) is a potent and selectivity chemical probe for CDKL5/GSK3.CDKL5/GSK3-IN-1 has potent inhibition of CDKL5 and GSK3α/β, with IC50 values of 4.6, 24 and 9.5 nM for CDKL5, GSK3β and GSK3α, respectively, in the NanoBRET assay. CDKL5/GSK3-IN-1 can be used for the research of CNS diseases .
loading...
    loading...